MORGAN STANLEY PLC/CALL/NIKE `B`/200/0.1/20.12.24 Stock

Warrant

DE000MB27VZ4

Market Closed - Börse Stuttgart 02:53:37 2024-05-28 am EDT
0.018 EUR +20.00% Intraday chart for MORGAN STANLEY PLC/CALL/NIKE `B`/200/0.1/20.12.24
Current month-14.29%
1 month-18.18%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-28 0.018 +20.00%
24-05-27 0.015 -25.00%
24-05-24 0.02 0.00%
24-05-23 0.02 0.00%
24-05-22 0.02 +33.33%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 02:53 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying NIKE, INC.
Issuer Morgan Stanley
WKN MB27VZ
ISINDE000MB27VZ4
Date issued 2023-01-10
Strike 200 $
Maturity 2024-12-20 (206 Days)
Parity 10 : 1
Emission price 0.79
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.79
Lowest since issue 0.014
Spread 0.02
Spread %50.00%

Company Profile

Nike, Inc. specializes in the design, manufacturing and marketing of sports shoes, clothing, and equipment. The group's products are sold primarily under the names Nike, Jordan, Converse Chuck Taylor, All Star, One Star, Star Chevron and Jack Purcell. Net sales break down by family of products as follows: - footwear (68.9%); - clothing (27.2%); - sports equipment (3.4%): golf equipment (golf clubs, balls, gloves, etc.), bags, balls, etc.; - other (0.5%). At the end of May 2023, products were being marketed through a network of 1,032 stores worldwide, through independent distributors, and via the Internet. Net sales are distributed geographically as follows: North America (44.3%), Europe/Middle East/Africa (27.5%), China (14.9%), Asia/Pacific and Latin America (13.2%) and other (0.1%).
Sector
-
More about the company

Ratings for Nike, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Nike, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
92 USD
Average target price
111.3 USD
Spread / Average Target
+20.93%
Consensus